Views: 1,249 | Downloads:
23
| Responses: 0
| XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Original ArticleOpen Access
Effect of Bitter Melon (Momordica Charantia Linn) on Level and Function of Natural Killer Cells in Cervical Cancer Patients with Radiotherapy
Kasinrerk W 
,
Limtraku PP
,
Limtraku PP DURIYA FONGMOON, MSc*,
PORN-NGAM LIMTRAKUL, PhD***
Cervical cancer patients have a defective immune system. There is a decrease of total white
blood cell count including lymphocytes and natural killer (NK) cells. NK cells, one type of lympho-
cytes, play a role to eliminate cancer cells by antibody dependent cell mediated cytotoxicity (ADCC)
mechanism. Previous studies have shown that P-glycoprotein ( 170 kDa, transmembrane protein) may
be a transporter for cytokine releasing in ADCC mechanism.
This study proposed to explore the role of bitter melon intake in cervical cancer patients
undergoing normal treatment (radiotherapy). Subjects were divided into three groups: 1) normal control
(women 35-55 years, n
=
35), 2) patient control (n
=
30) and 3) patient treatment (n
=
30) groups.
Patient control and patient treatment groups were cervical cancer patients (stage II or III) treated with
radiotherapy (without or with bitter melon ingestion). Blood samples of patient control and patient
treatment groups were analyzed for NK cells percentage and P-glycoprotein level. Bitter melon is a
Thai herb. Previous studies have shown that bitter melon can stimulate lymphocyte activity
in vitro
and
in vivo
(mouse). The authors hope that bitter melon could stimulate the increase of NK cells
percentage and P-glycoprotein level on the membrane in blood samples from cervical cancer patients
who ingest bitter melon.
The results showed an increased percentage of NK cells in patient control and patient treat-
ment groups. The increase in each group is significant (p
<
0.05) when compared with the percentage
of NK cells from second and third blood sampling time (after radiation with of without bitter melon
intake for 45 and 90 days) with first blood sampling time (before treatment). The results also show a
significant decrease of P-glycoprotein level (p
<
0.05) in second and third blood sampling times when
compared with first blood sampling time of the patient treatment group. There was no significant
difference of P-glycoprotein (P-gp) level from first, second and third blood sampling times in patient
control group.
62
PORN-NGAM LIMTRAKUL, PhD***
Cervical cancer patients have a defective immune system. There is a decrease of total white
blood cell count including lymphocytes and natural killer (NK) cells. NK cells, one type of lympho-
cytes, play a role to eliminate cancer cells by antibody dependent cell mediated cytotoxicity (ADCC)
mechanism. Previous studies have shown that P-glycoprotein ( 170 kDa, transmembrane protein) may
be a transporter for cytokine releasing in ADCC mechanism.
This study proposed to explore the role of bitter melon intake in cervical cancer patients
undergoing normal treatment (radiotherapy). Subjects were divided into three groups: 1) normal control
(women 35-55 years, n
=
35), 2) patient control (n
=
30) and 3) patient treatment (n
=
30) groups.
Patient control and patient treatment groups were cervical cancer patients (stage II or III) treated with
radiotherapy (without or with bitter melon ingestion). Blood samples of patient control and patient
treatment groups were analyzed for NK cells percentage and P-glycoprotein level. Bitter melon is a
Thai herb. Previous studies have shown that bitter melon can stimulate lymphocyte activity
in vitro
and
in vivo
(mouse). The authors hope that bitter melon could stimulate the increase of NK cells
percentage and P-glycoprotein level on the membrane in blood samples from cervical cancer patients
who ingest bitter melon.
The results showed an increased percentage of NK cells in patient control and patient treat-
ment groups. The increase in each group is significant (p
<
0.05) when compared with the percentage
of NK cells from second and third blood sampling time (after radiation with of without bitter melon
intake for 45 and 90 days) with first blood sampling time (before treatment). The results also show a
significant decrease of P-glycoprotein level (p
<
0.05) in second and third blood sampling times when
compared with first blood sampling time of the patient treatment group. There was no significant
difference of P-glycoprotein (P-gp) level from first, second and third blood sampling times in patient
control group.
62
Download:
PDF